As of Jul 31
| -0.001 / -0.24%|
The 2 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 3.63, with a high estimate of 5.00 and a low estimate of 2.25. The median estimate represents a +784.15% increase from the last price of 0.41.
The current consensus among 2 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.